Prasugrel versus clopidogrel for acute coronary syndromes.
Publication
, Journal Article
Roe, MT; Ohman, EM; TRILOGY ACS Investigators
Published in: N Engl J Med
January 10, 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
January 10, 2013
Volume
368
Issue
2
Start / End Page
188 / 189
Location
United States
Related Subject Headings
- Ticlopidine
- Thiophenes
- Platelet Aggregation Inhibitors
- Piperazines
- Myocardial Infarction
- Male
- Humans
- General & Internal Medicine
- Female
- Angina, Unstable
Citation
APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., Ohman, E. M., & TRILOGY ACS Investigators. (2013). Prasugrel versus clopidogrel for acute coronary syndromes. N Engl J Med, 368(2), 188–189. https://doi.org/10.1056/NEJMc1213509
Roe, Matthew T., E Magnus Ohman, and TRILOGY ACS Investigators. “Prasugrel versus clopidogrel for acute coronary syndromes.” N Engl J Med 368, no. 2 (January 10, 2013): 188–89. https://doi.org/10.1056/NEJMc1213509.
Roe MT, Ohman EM, TRILOGY ACS Investigators. Prasugrel versus clopidogrel for acute coronary syndromes. N Engl J Med. 2013 Jan 10;368(2):188–9.
Roe, Matthew T., et al. “Prasugrel versus clopidogrel for acute coronary syndromes.” N Engl J Med, vol. 368, no. 2, Jan. 2013, pp. 188–89. Pubmed, doi:10.1056/NEJMc1213509.
Roe MT, Ohman EM, TRILOGY ACS Investigators. Prasugrel versus clopidogrel for acute coronary syndromes. N Engl J Med. 2013 Jan 10;368(2):188–189.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
January 10, 2013
Volume
368
Issue
2
Start / End Page
188 / 189
Location
United States
Related Subject Headings
- Ticlopidine
- Thiophenes
- Platelet Aggregation Inhibitors
- Piperazines
- Myocardial Infarction
- Male
- Humans
- General & Internal Medicine
- Female
- Angina, Unstable